69 related articles for article (PubMed ID: 10961674)
1. Tautomers of styrylquinoline derivatives containing a methoxy substituent: computation of their population in aqueous solution and their interaction with RSV integrase catalytic core.
Ouali M; Laboulais C; Leh H; Gill D; Xhuvani E; Zouhiri F; Desmaele D; d'Angelo J; Auclair C; Mouscadet JF; Le Bret M
Acta Biochim Pol; 2000; 47(1):11-22. PubMed ID: 10961674
[TBL] [Abstract][Full Text] [Related]
2. Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives.
Ouali M; Laboulais C; Leh H; Gill D; Desmaële D; Mekouar K; Zouhiri F; d'Angelo J; Auclair C; Mouscadet JF; Le Bret M
J Med Chem; 2000 May; 43(10):1949-57. PubMed ID: 10821707
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
Yang ZN; Mueser TC; Bushman FD; Hyde CC
J Mol Biol; 2000 Feb; 296(2):535-48. PubMed ID: 10669607
[TBL] [Abstract][Full Text] [Related]
4. Purification of recombinant Rous sarcoma virus integrase possessing physical and catalytic properties similar to virion-derived integrase.
McCord M; Stahl SJ; Mueser TC; Hyde CC; Vora AC; Grandgenett DP
Protein Expr Purif; 1998 Nov; 14(2):167-77. PubMed ID: 9790878
[TBL] [Abstract][Full Text] [Related]
5. A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.
Konsavage WM; Burkholder S; Sudol M; Harper AL; Katzman M
J Virol; 2005 Apr; 79(8):4691-9. PubMed ID: 15795255
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of HIV-1 integrase inhibition by styrylquinoline derivatives in vitro.
Deprez E; Barbe S; Kolaski M; Leh H; Zouhiri F; Auclair C; Brochon JC; Le Bret M; Mouscadet JF
Mol Pharmacol; 2004 Jan; 65(1):85-98. PubMed ID: 14722240
[TBL] [Abstract][Full Text] [Related]
7. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2000 Apr; 53(4):308-15. PubMed ID: 10685051
[TBL] [Abstract][Full Text] [Related]
8. Computer aided study of ligand binding with catalytic domain of Avian sarcoma virus integrase and its ligand binding loops.
Kumar A; Shankar S; Kothekar V
J Biomol Struct Dyn; 2001 Dec; 19(3):449-58. PubMed ID: 11790143
[TBL] [Abstract][Full Text] [Related]
9. Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase.
Konsavage WM; Sudol M; Katzman M
Virology; 2008 Sep; 379(2):223-33. PubMed ID: 18687451
[TBL] [Abstract][Full Text] [Related]
10. Integrase of Mason-Pfizer monkey virus.
Snásel J; Krejcík Z; Jencová V; Rosenberg I; Ruml T; Alexandratos J; Gustchina A; Pichová I
FEBS J; 2005 Jan; 272(1):203-16. PubMed ID: 15634344
[TBL] [Abstract][Full Text] [Related]
11. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
[TBL] [Abstract][Full Text] [Related]
12. Correlated ab initio study of nucleic acid bases and their tautomers in the gas phase, in a microhydrated environment and in aqueous solution. guanine: surprising stabilization of rare tautomers in aqueous solution.
Hanus M; Ryjácek F; Kabelác M; Kubar T; Bogdan TV; Trygubenko SA; Hobza P
J Am Chem Soc; 2003 Jun; 125(25):7678-88. PubMed ID: 12812509
[TBL] [Abstract][Full Text] [Related]
13. Crystal and electronic structures of magnesium(II), copper(II), and mixed magnesium(II)-copper(II) complexes of the quinoline half of styrylquinoline-type HIV-1 integrase inhibitors.
Courcot B; Firley D; Fraisse B; Becker P; Gillet JM; Pattison P; Chernyshov D; Sghaier M; Zouhiri F; Desmaële D; d'Angelo J; Bonhomme F; Geiger S; Ghermani NE
J Phys Chem B; 2007 May; 111(21):6042-50. PubMed ID: 17488111
[TBL] [Abstract][Full Text] [Related]
14. Loop202-208 in avian sarcoma virus integrase mediates tetramer assembly and processing activity.
Bosserman MA; O'Quinn DF; Wong I
Biochemistry; 2007 Oct; 46(40):11231-9. PubMed ID: 17845008
[TBL] [Abstract][Full Text] [Related]
15. Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.
Sato M; Kawakami H; Motomura T; Aramaki H; Matsuda T; Yamashita M; Ito Y; Matsuzaki Y; Yamataka K; Ikeda S; Shinkai H
J Med Chem; 2009 Aug; 52(15):4869-82. PubMed ID: 19719237
[TBL] [Abstract][Full Text] [Related]
16. A crystal structure of the catalytic core domain of an avian sarcoma and leukemia virus integrase suggests an alternate dimeric assembly.
Ballandras A; Moreau K; Robert X; Confort MP; Merceron R; Haser R; Ronfort C; Gouet P
PLoS One; 2011; 6(8):e23032. PubMed ID: 21857987
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the functional domains of human foamy virus integrase using chimeric integrases.
Lee HS; Kang SY; Shin CG
Mol Cells; 2005 Apr; 19(2):246-55. PubMed ID: 15879710
[TBL] [Abstract][Full Text] [Related]
18. Experimental/theoretical electrostatic properties of a styrylquinoline-type HIV-1 integrase inhibitor and its progenitors.
Firley D; Courcot B; Gillet JM; Fraisse B; Zouhiri F; Desmaële D; d'Angelo J; Ghermani NE
J Phys Chem B; 2006 Jan; 110(1):537-47. PubMed ID: 16471566
[TBL] [Abstract][Full Text] [Related]
19. Requirements for minus-strand transfer catalyzed by Rous sarcoma virus reverse transcriptase.
Werner S; Vogel-Bachmayr K; Hollinderbäumer B; Wöhrl BM
J Virol; 2001 Nov; 75(21):10132-8. PubMed ID: 11581381
[TBL] [Abstract][Full Text] [Related]
20. Tetrameric structure of a serine integrase catalytic domain.
Yuan P; Gupta K; Van Duyne GD
Structure; 2008 Aug; 16(8):1275-86. PubMed ID: 18682229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
